A study conducted by researchers at the Johns Hopkins Kimmel Cancer Center sheds light on the crucial involvement of transcription factors in the development of different colorectal cancer subtypes. The expression of these proteins seems to play a central role in the degree of DNA methylation across the genome, which can influence the development of specific types of colorectal cancers. The study was published in Proceedings of the National Academy of Sciences.
The study suggests that analyzing the expression of these transcription factors in patients with colorectal cancer could lead to identifying biomarkers that predict overall survival. Moreover, patients belonging to a subgroup of colorectal cancer, known for having better survival rates and responding well to immune checkpoint therapy, may be identified through these biomarkers..
The researchers also observed similar patterns of transcription factor expression in precancerous polyps, potentially indicating a need for closer follow-up to prevent cancer development in certain patients. Traditionally, DNA methylation changes in cancers have been described in promoter regions, which initiate the transcription process, but the exact mechanisms causing these changes remained unclear.
Search Antibodies Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.
The laboratory studies on genetic material taken from colon tumors and precancerous polyps provided insights into the origins and evolution of different molecular subtypes of colorectal cancers. The researchers found that methylation changes in some genome regions could be linked to downregulated transcription factors, while other colon cancers showed upregulated or increased expression of transcription factors based on genetic alterations associated with the cancer.
These findings suggest that transcription factor expression changes and DNA methylation changes occur early during tumor development. Identifying the specific set of transcription factors could help stratify colorectal cancer prognosis and lead to better therapeutic strategies across different subtypes of colorectal cancers.